On August 27, 2025 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, reported that company management will participate at multiple upcoming investor conferences (Press release, Xencor, AUG 27, 2025, View Source [SID1234655522]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference
Date: Wednesday, September 3, 2025
Presentation Time: 3:00 p.m. ET / 12:00 p.m. PT
Cantor Global Healthcare Conference 2025
Date: Thursday, September 4, 2025
Presentation Time: 8:00 a.m. ET / 5:00 a.m. PT

Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.

On August 27, 2025 enGene Holdings Inc. (Nasdaq: ENGN or "enGene"), a clinical-stage, non-viral gene therapy company, reported that management will participate in the following investor conferences in September (Press release, enGene, AUG 27, 2025, View Source [SID1234655538]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference
Date: Wednesday, September 3, 2025
Time: 8:45 a.m. ET

H.C. Wainwright 27th Annual Global Investment Conference
Date: Monday, September 8, 2025
Time: 1:30 p.m. ET

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: Wednesday, September 10, 2025
Time: 1:50 p.m. ET

A live webcast of these events can be accessed under the "Investors" section of the enGene website at www.engene.com and will be archived there for 90 days.

On August 27, 2025 Bio-Techne Corporation (NASDAQ: TECH) reported that it will present at the following investor conferences (Press release, Bio-Techne, AUG 27, 2025, View Source [SID1234655508]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference
September 3, 2025
10:15 AM EDT

Baird 2025 Global Healthcare Conference
September 9, 2025
9:05 AM EDT

Morgan Stanley 23rd Annual Global Healthcare Conference
September 10, 2025
10:45 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne’s Investor Relations website at View Source

On August 27, 2025 Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, reported that the Company’s CEO, Gil Efron will participate in a fireside chat and 1×1 investor meeting at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8-10, 2025 (Press release, Purple Biotech, AUG 27, 2025, View Source;id=362152&p=2397977&I=1206939-c7Z3G6f3m8 [SID1234655523]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details are as follows:

H.C. Wainwright 27th Annual Global Investment Conference

Format: Fireside Chat
Date: Wednesday, September 10, 2025
Time: 11:30 AM ET

Management will be holding 1 x 1 meetings as well. Please schedule through the H.C. Wainwright conference portal.

On August 27, 2025 Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, reported that company management will participate in fireside chats at four upcoming investor conferences (Press release, Disc Medicine, AUG 27, 2025, View Source [SID1234655509]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 3rd at 10:55 a.m. ET.
2025 Wells Fargo Healthcare Conference on Thursday, September 4th at 4:30 p.m. ET.
H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9th at 12:00 p.m. ET.
Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10th at 1:05 p.m. ET.

Live webcasts of the fireside chats will be available through the investor relations section of the Company’s website at ir.discmedicine.com and an archived replay will be available after the event.